- Home
- OFLX vs TRDA Comparison
OFLX vs TRDA Comparison
Compare OFLX & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- TRDA
- Stock Information
- Founded
- OFLX 1975
- TRDA 2016
- Country
- OFLX United States
- TRDA United States
- Employees
- OFLX N/A
- TRDA N/A
- Industry
- OFLX Industrial Specialties
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- TRDA Health Care
- Exchange
- OFLX Nasdaq
- TRDA Nasdaq
- Market Cap
- OFLX 527.8M
- TRDA 609.7M
- IPO Year
- OFLX 2005
- TRDA 2021
- Fundamental
- Price
- OFLX $48.74
- TRDA $18.05
- Analyst Decision
- OFLX
- TRDA Strong Buy
- Analyst Count
- OFLX 0
- TRDA 3
- Target Price
- OFLX N/A
- TRDA $23.33
- AVG Volume (30 Days)
- OFLX 16.7K
- TRDA 132.6K
- Earning Date
- OFLX 10-30-2024
- TRDA 11-05-2024
- Dividend Yield
- OFLX 2.78%
- TRDA N/A
- EPS Growth
- OFLX N/A
- TRDA N/A
- EPS
- OFLX 1.81
- TRDA 1.55
- Revenue
- OFLX $102,863,000.00
- TRDA $215,232,000.00
- Revenue This Year
- OFLX N/A
- TRDA $47.63
- Revenue Next Year
- OFLX N/A
- TRDA N/A
- P/E Ratio
- OFLX $27.35
- TRDA $11.77
- Revenue Growth
- OFLX N/A
- TRDA 146.92
- 52 Week Low
- OFLX $43.86
- TRDA $10.95
- 52 Week High
- OFLX $85.92
- TRDA $20.49
- Technical
- Relative Strength Index (RSI)
- OFLX 39.03
- TRDA 50.91
- Support Level
- OFLX $53.04
- TRDA $17.09
- Resistance Level
- OFLX $53.50
- TRDA $20.49
- Average True Range (ATR)
- OFLX 1.62
- TRDA 0.96
- MACD
- OFLX -0.60
- TRDA -0.20
- Stochastic Oscillator
- OFLX 1.41
- TRDA 28.24
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.